Domača stranJNJB34 • BVMF
add
Johnson & Johnson
Prejšnji trg. dan.
59,86 R$
Dnevni razpon
59,86 R$ - 61,62 R$
Letni razpon
48,98 R$ - 63,86 R$
Tržna kapitalizacija
375,72 mrd. USD
Povprečni obseg
12,37 tis.
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 22,47 mrd. | 5,25 % |
Stroški poslovanja | 10,20 mrd. | 18,80 % |
Čisti dohodek | 2,69 mrd. | −89,65 % |
Čista dobičkovnost prihodkov | 11,99 | −90,16 % |
Earnings per share | 2,42 | −9,02 % |
EBITDA | 7,36 mrd. | −10,41 % |
Efektivna davčna stopnja | 19,29 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 20,30 mrd. | −13,67 % |
Skupna sredstva | 178,29 mrd. | 7,36 % |
Skupne obveznosti | 108,13 mrd. | 14,02 % |
Celoten lastniški kapital | 70,16 mrd. | — |
Shares outstanding | 2,41 mrd. | — |
Razmerje P/B | 2,05 | — |
Donosnost sredstev | 7,66 % | — |
Donosnost kapitala | 12,58 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 2,69 mrd. | −89,65 % |
Denar iz dejavnosti | 7,99 mrd. | — |
Denar iz naložb | −3,13 mrd. | — |
Denar iz financiranja | −9,88 mrd. | — |
Neto sprememba denarnih sredstev | −4,90 mrd. | — |
Prost denarni tok | 5,50 mrd. | — |
Vizitka
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Wikipedia
Generalni direktor
Datum ustanovitve
jan. 1886
Sedež organizacije
Spletno mesto
Zaposleni
131.900
